Page last updated: 2024-10-23

azathioprine and Eye Injuries, Penetrating

azathioprine has been researched along with Eye Injuries, Penetrating in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Eye Injuries, Penetrating: Deeply perforating or puncturing type intraocular injuries.

Research Excerpts

ExcerptRelevanceReference
"Sympathetic ophthalmia is a rare form of autoimmune uveitis and manifests in 90% of cases within the first year after penetrating injuries or surgical interventions."1.30[Sympathetic ophthalmia 50 years after penetrating injury. A case report]. ( Frühauf, A; Hellmund, K; Naumann, GO; Seiler, T, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdullah, M1
Chowdhury, FQ1
Akhanda, AH1
Hossain, MI1
Islam, MR1
Aminul, F1
Hellmund, K1
Frühauf, A1
Seiler, T1
Naumann, GO1

Other Studies

2 other studies available for azathioprine and Eye Injuries, Penetrating

ArticleYear
Sympathetic Ophthalmitis: A Rare Case Report.
    Mymensingh medical journal : MMJ, 2019, Volume: 28, Issue:2

    Topics: Adolescent; Azathioprine; Eye Injuries, Penetrating; Humans; Immunomodulation; Immunosuppressive Age

2019
[Sympathetic ophthalmia 50 years after penetrating injury. A case report].
    Klinische Monatsblatter fur Augenheilkunde, 1998, Volume: 213, Issue:3

    Topics: Aged; Autoimmune Diseases; Azathioprine; Combined Modality Therapy; Cyclosporine; Eye Enucleation; E

1998